On July 19, 2023, Axios published an article highlighting the citizen petition filed by CUSP that urges the FDA to categorize a widely utilized clinical decision support software (CDS) a misbranded medical device. The petition further implores the FDA to recall the CDS to protect patient safety. 

The article discusses key aspects of the petition and explores potential implications for how the FDA might respond, noting, “the agency is feeling increasing pressure to manage the overdose crisis and keep up with the rise of technology in health care.” 

Read the full article here.